Urgent call to kick-start life-saving cancer research so cancer patients don’t get left behind 14 Jul 2020
Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer 26 Jun 2020
Approval of targeted therapies first line for prostate cancer ‘will ease COVID-19 pressures’ 06 May 2020
The ICR responds to approval of abiraterone as first-line treatment for advanced prostate cancer on the NHS in Scotland 13 Jan 2020
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer 30 Sep 2019
ESMO 2019: Modern chemotherapy drug better than second targeted hormone therapy against resistant prostate cancer 30 Sep 2019